About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- fentanyl (transdermal patches, solution for injection - nationally authorised product only)
- Procedure number
- PSUSA/00001370/202304
Documents
Fentanyl (transdermal patches, solution for injection - nationally authorised product only) : List of nationally authorised medicinal products - PSUSA/00001370/202304
English (EN) (394.22 KB - PDF)
Fentanyl (transdermal patches, solution for injection - nationally authorised product only) : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001370/202304
English (EN) (207.67 KB - PDF)
български (BG) (242.83 KB - PDF)
español (ES) (154.05 KB - PDF)
čeština (CS) (241.11 KB - PDF)
dansk (DA) (152.25 KB - PDF)
Deutsch (DE) (157.81 KB - PDF)
eesti keel (ET) (147.04 KB - PDF)
ελληνικά (EL) (235.51 KB - PDF)
français (FR) (237.11 KB - PDF)
hrvatski (HR) (234.49 KB - PDF)
íslenska (IS) (153.42 KB - PDF)
italiano (IT) (230.42 KB - PDF)
latviešu valoda (LV) (238.7 KB - PDF)
lietuvių kalba (LT) (240.36 KB - PDF)
magyar (HU) (238.08 KB - PDF)
Malti (MT) (247.46 KB - PDF)
Nederlands (NL) (152.3 KB - PDF)
norsk (NO) (152.21 KB - PDF)
polski (PL) (308.57 KB - PDF)
português (PT) (153 KB - PDF)
română (RO) (234.75 KB - PDF)
slovenčina (SK) (245.18 KB - PDF)
slovenščina (SL) (234.2 KB - PDF)
Suomi (FI) (149.11 KB - PDF)
svenska (SV) (153.04 KB - PDF)